INTRODUCTION
============

Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by inattention, hyperactivity, and impulsivity.[@b1-cpn-16-407] ADHD develops during preschool. While hyperactivity tends to decline with age, symptoms of inattention are more likely to persist to adulthood.[@b2-cpn-16-407],[@b3-cpn-16-407] The rate of ADHD persistence to adulthood is 65%, including a partial remission state.[@b3-cpn-16-407]

Adult ADHD is prevalent (demonstrated in approximately 4.4% of adult populations),[@b4-cpn-16-407],[@b5-cpn-16-407] and causes substantial functional impairment.[@b6-cpn-16-407],[@b7-cpn-16-407] Adult ADHD is associated with psychiatric disorders such as mood disorder, anxiety disorder, or substance abuse, as well as antisocial and illegal behaviors.[@b8-cpn-16-407],[@b9-cpn-16-407] Accordingly, adult ADHD causes long-term health and economic burdens, including medical health, education, social service, and criminal justice costs.[@b10-cpn-16-407]--[@b12-cpn-16-407] Despite the consequences of the clinical implications of adult ADHD, little clinical attention is paid to adult ADHD.[@b13-cpn-16-407] In fact, fewer than 20% of adults with ADHD are diagnosed or treated, and the majority of adult ADHD patients remain untreated or in states of partial remission.[@b14-cpn-16-407]--[@b16-cpn-16-407] If adult ADHD were to be successfully diagnosed and treated, then the progression of these individuals to further functional impairment could be prevented.[@b17-cpn-16-407]

Recent studies have demonstrated significantly higher functional impairment in adults with ADHD compared to normal controls.[@b18-cpn-16-407] A previous study also reported that the severity of ADHD symptoms was significantly correlated with impairment to patient quality of life.[@b19-cpn-16-407] These findings, however, are based on the results of studies conducted in Western populations. Little is known about the relationship between functional impairment and the severity of ADHD symptoms in Asian populations.

Anxiety is a commonly reported condition with a prevalence ranging from 34% to 40% in patients with ADHD.[@b20-cpn-16-407],[@b21-cpn-16-407] Anxiety is a strong risk factor for other forms of psychiatric disorders, such as depression, somatoform disorder, conduct disorder, and substance abuse.[@b22-cpn-16-407]--[@b25-cpn-16-407] Anxiety adversely impacts self-esteem, social relationships, and academic performance.[@b26-cpn-16-407]--[@b28-cpn-16-407] In addition, anxiety is strongly associated with substantial functional impairment.[@b29-cpn-16-407] It is unclear, however, whether anxiety or the severity of ADHD symptoms are associated with functional impairment or whether anxiety mediates this relationship. Rigorous efforts to identify factors that relate functional impairment and ADHD are necessary in Asian populations in order to develop more therapeutically useful assessments and strategies for intervention.

The purpose of this study was to compare the severity of functional impairment in adults with and without ADHD, and to explore the mediating role of anxiety between ADHD symptoms and functional impairment.

METHODS
=======

Study Design
------------

The original sample consisted of 51 ADHD subjects and 158 normal control subjects. Patients with ADHD between the ages of 18 and 45 years were recruited from a set of psychiatric outpatients visiting Department of Psychiatry, Samsung Medical Center. For each ADHD subject, psychiatric assessment was conducted by master's level clinical psychologist using the Mini-International Neuropsychiatric Interview (MINI)[@b30-cpn-16-407] to confirm the diagnosis of ADHD and to identify comorbidities. Control participants were recruited via advertisements in Universities of Gyeonggi District and Seoul Metropolitan area in Korea. No clinical history was collected for the control group. Among the 158 healthy subjects in the control group, 51 participants were age, sex-matched to the ADHD group using propensity score matching. For most analyses, this group was designated the "healthy control" group. Thus the sample included 51 adult ADHD patients and 51 sex-matched healthy controls. Each subject was asked to complete psychological self-reports. ADHD severity was assessed with the Conners Adult ADHD Rating Scales (CAARS).[@b31-cpn-16-407] The CAARS consists of four subscales: inattention/memory problems, hyperactivity/restlessness, impulsivity/emotional lability, and problems with self-concept. The Beck Depression Inventory (BDI)[@b32-cpn-16-407] and the Spielberg Trait Anxiety Inventory (STAI-T)[@b33-cpn-16-407] were also administered to assess depression and anxiety. Additionally, the Sheehan Disability Scales (SDS),[@b34-cpn-16-407] which has been widely used among patients with various psychiatric illnesses, was used to examine participant functional impairment and quality of life. The Institutional Review Board of Samsung Medical Center approved this study, and all participants provided written informed consent.

Measurement
-----------

### The Conners Adult ADHD Rating Scale (CAARS)[@b31-cpn-16-407]

The CAARS is a quantitative measurement tool used to assess adult ADHD symptoms. The scale consists of four subscales that measure inattention/executive function, hyperactivity/restlessness, impulsivity/emotional lability, and problems with self-concept. Each item is scored on a four-point Likert scale ranging from 0 to 3 (0, not at all or never; 1, just a little or once in a while; 2, pretty much or often; and 3, very much or very frequently). We used the Korean version (CAARS-K),[@b35-cpn-16-407] which has good internal consistency (Cronbach's α=0.79--0.85).

### Beck Depression Inventory (BDI)[@b32-cpn-16-407],[@b36-cpn-16-407]

The BDI is a well-validated scale designed to measure depressive symptom severity. It is a self-report questionnaire comprised of 21 items using a four-point Likert scale. Overall score varies between 0 and 63, with score ranges of 0--13 (not at all), 14--19 (mildly), 20--28 (moderately), and 29--63 (severe). The Korean version of BDI[@b36-cpn-16-407] with good internal consistency (Cronbach's α=0.83--0.88) and validity was used.

### Spielberg Trait Anxiety Inventory (STAI-T)[@b33-cpn-16-407],[@b37-cpn-16-407]

The STAI-T questionnaire is widely used to measure trait anxiety. The STAI-T contains 20 four-point Likert scale items. Trait anxiety items assess how subjects generally feel. Total scores range from 20 to 80. Higher scores indicate more severe anxiety levels. The Korean version[@b37-cpn-16-407] used in this study had good reliability and validity.

### Sheehan Disability Scale (SDS)[@b38-cpn-16-407],[@b39-cpn-16-407]

The SDS self-report questionnaire measures disability or functional impairment. It consists of three dimensions including work/school, social life/leisure activities, and family life/home responsibilities. Each item ranges from 0 to 10: 0 (not at all), 1--3 (mildly), 4--6 (moderately), 7--0 (markedly), and 10 (extremely). The total score ranges from 0 to 30 and higher scores indicate higher disability level.

Statistical Analysis
--------------------

We assessed differences between ADHD and control subjects using *t* tests for continuous variables and chi-square tests for categorical outcomes. Pearson correlation coefficients were used to evaluate relationships between clinical variables.

Mediation models were developed to examine the influence of ADHD symptom severity on functional impairment. Separate model were estimated for each independent variable (subscales from CAARS) and dependent variable (SDS scores). Mediation models estimate the indirect effects of an independent variable (in this case, ADHD symptom severity) on a dependent variable (functional impairment) after accounting for a mediator (anxiety). We used 5,000 bootstrap resamples to provide stable estimates of direct, indirect, and total effects. Confidence intervals were established using the bias-corrected and accelerated method. Mediation was tested using the Hayes[@b40-cpn-16-407] PROCESS modeling approach in model 4 of IBM SPSS Statistics software version 21.0 (IBM Co., Armonk, NY, USA). This analytic approach permitted the examination of both direct and indirect effects of ADHD symptom severity and anxiety on functional impairment in subjects with adult ADHD.

All tests were two-tailed, and alpha level was set at 0.05 for all analyses. We calculated all statistics using IBM SPSS Statistics software version 21.0.

RESULTS
=======

Demographic and clinical characteristics for the two groups are shown in [Table 1](#t1-cpn-16-407){ref-type="table"}. The study sample included 51 ADHD adults (33 males and 18 females) and 51 healthy control subjects (33 males and 18 females). There was no significant difference in gender distribution, which was statistically controlled. There were significant between group differences in age, education levels, and marital status. Subjects in the ADHD group showed significantly higher CAARS (*p*\<0.001), BDI (*p*\<0.001), STAI-T (*p*\<0.001), and SDS (*p*= 0.007) scores compared to healthy controls.

Pearson correlations between SDS and psychological symptoms including BDI, STAI-T, and CAARS were significant. Higher psychological symptom severity (i.e., depression, anxiety, and ADHD symptoms) was associated with worse functional impairment ([Table 2](#t2-cpn-16-407){ref-type="table"}).

We conducted a regression-based mediation analysis according to Preacher and Hayes[@b41-cpn-16-407] for all four measures of ADHD (i.e., inattention/executive function, hyper-activity/restlessness, impulsivity/emotional lability, and problems with self-concept). ADHD symptoms served as predictors, SDS scores served as the criterion, and STAI-T scores served as mediators in this analysis ([Figs. 1](#f1-cpn-16-407){ref-type="fig"}[](#f2-cpn-16-407){ref-type="fig"}[](#f3-cpn-16-407){ref-type="fig"}--[4](#f4-cpn-16-407){ref-type="fig"}). Whereas the indirect effects of inattention (B=0.523, standard error \[SE\]=0.150, 95% confidence interval \[CI\]= 0.285--0.872), hyperactivity (B=0.254, SE=0.090, 95% CI=0.107--0.458), impulsivity (B=0.338, SE=0.123, 95% CI=0.114--0.608), and problems with self-concept (B=1.06, SE=0.287, 95% CI=0.561--1.691) via anxiety were significant, the direct effects of inattention, hyper-activity, impulsivity, and problems with self-concept were not significant. Given that the total effects were significant and the direct effects were not significant, we are able to conclude that the pathway between ADHD symptom severity and functional impairment is completely mediated by anxiety.

DISCUSSION
==========

The primary goal of this study was to examine the associations between ADHD symptoms, anxiety, and functional impairment in adult patients with ADHD. Mediation analysis revealed significant indirect effects of inattention, hyperactivity, emotional lability/impulsivity, and problems with self-concept, but these were uniquely mediated by anxiety. This study represents the first investigation to empirically test the hypothesis that ADHD symptoms affect functional impairment via the influence of ADHD symptoms on anxiety among adult ADHD patients.

This study identified anxiety as a mediator between ADHD symptom severity and functional impairment. Anxiety has been investigated in various psychiatric disorders. Previous research has reported that anxiety is a significant relevant factor predicting treatment response and prognosis. High anxiety sensitivity is a key predictor for panic disorder severity.[@b42-cpn-16-407] In addition, according to recent research, anxiety sensitivity is a risk factor for mood disorder, psychosomatic disorder, post-traumatic stress disorder, and so on.[@b43-cpn-16-407]--[@b45-cpn-16-407] Some reports claim that suicide ideation is related to anxiety sensitivity,[@b46-cpn-16-407] and poor impulse control combined with high anxiety may impact suicidal ideation and suicide attempts.[@b47-cpn-16-407] Generally, ADHD patients suffer from impulsivity, response inhibition, and reward delay problems.[@b48-cpn-16-407],[@b49-cpn-16-407] Anxiety comorbid with ADHD has been shown to predict poor behavioral regulation[@b50-cpn-16-407] and enhanced the association between ADHD and oppositional defiant disorder/conduct disorder.[@b51-cpn-16-407] Comorbid anxiety has been shown to be an important precursor, contributing to the development of externalizing problems in ADHD children.[@b51-cpn-16-407]--[@b55-cpn-16-407] A better understanding of factors that influence anxiety may be beneficial for targeting areas in need of improvement in the diagnosis and treatment of ADHD. Considering comorbid anxiety in adult ADHD treatment will contribute to improve treatment outcome and quality of life.

This study confirmed previous findings on the existence of functional impairment in adult ADHD patients. Although SDS scores among subjects in this study were under the cut-off value (remission \<6), adult ADHD patients were shown to have significantly higher functional impairment than healthy control subjects. Additionally, we also revealed higher anxiety levels in adults with ADHD and a significant association between anxiety and ADHD symptom severity. These findings are consistent with the results of previous studies.[@b56-cpn-16-407] Recent studies have shown that both ADHD and anxiety disorders share a genetic pathophysiology.[@b57-cpn-16-407],[@b58-cpn-16-407] The mechanisms involved in this association need to be further studied.

Our results indicated that all the subscales of ADHD mediated by trait anxiety had significant effects on functional impairment. Among all the subscales of CAARS, predominantly impulsivity/emotional lability mediated by trait anxiety. Emotional dysregulation is a major core ADHD symptom, and has been shown to predict adult ADHD severity independent of comorbid disorders.[@b59-cpn-16-407] Consistent with previous reports, impulsivity significantly affected functional impairment in ADHD adults. Persistent impulsive ADHD symptoms in adulthood indicate behavioral inhibition dysfunction due to delayed brain maturation, which could eventually be a major functional impairment source.[@b60-cpn-16-407],[@b61-cpn-16-407] These results have important implications for ADHD treatment strategies and/or prognosis.

While inattention, hyperactivity, and impulsivity cause functional impairment in ADHD adults, problems with self-concept also lead to functional impairment. Previous researches reported that patients with adult ADHD showed significantly greater self-concept problems compared to control groups.[@b62-cpn-16-407]--[@b64-cpn-16-407] Problems with self-concept included negative beliefs about the self-caused individuals to develop maladaptive coping strategies, including avoidance and procrastination. Also, untreated ADHD has been associated with decreased social skills, including poor peer or familial relationships, riskier sexual/physical activity, and increased peer victimization/ bullying.[@b65-cpn-16-407],[@b66-cpn-16-407]

This study has some limitations. First, for adult patients with ADHD, the study did not exclude comorbid disorders. We recruited adult patients with ADHD referred from a community sample, including some patients with comorbid disorders. Some selection bias may exist. However, ADHD is frequently comorbid with psychiatric illness in almost 80% of subjects.[@b67-cpn-16-407],[@b68-cpn-16-407] Accordingly, this sample may reflect a community sample of adult ADHD patients. Second, we measured attentional problems and impulsivity using self-reports instead of objective assessments. Thus, individual discrepancies are likely to exist between objective symptom severity and self-reported symptom severity. Third, this study was cross-sectional, so causal relationships could not be established. Longitudinal prospective studies will be needed to confirm our results. Fourth, we did not assess possible comorbidities in healthy control subjects. In addition, psychiatric history was not excluded in the control group. It is possible that the STAI-T increments were due to potential factors not assessed in the current study, such as temperament, parenting style, or early life experiences. Nevertheless, this study utilized structured and systematic interview-based instruments to evaluate aspects of adult ADHD that are relatively difficult to detect. We improved statistical power by controlling for age, sex-based factors in the analysis.

In conclusion, this study provided strong evidence that anxiety management must be treated as an important aspect of comprehensive therapeutic strategies for adult ADHD patients. Generally, psychiatrists and physicians recognize adult ADHD as a prognosis of benign-spontaneous remission, so less clinical attention is paid to adult ADHD compared to child and adolescent ADHD. This study intended to encourage more clinical attention to and consideration of ADHD diagnosis in adult patients with psychiatric illness.
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###### 

Demographic and clinical characteristic of adult ADHD group and healthy control

  Characteristic                  ADHD (n=51)   Healthy control (n=51)   T (or χ^2^)   *p* value
  ------------------------------- ------------- ------------------------ ------------- --------------------------------------------------
  Age (yr)                        27.82±8.90    24.33±4.86               2.46          0.016
  Gender, male                    33 (64.7)     33 (64.7)                0.00          0.582
  Education                                                                            
   Elementary school              2                                      9.93          0.019
   Middle school                  31            28                                     
   High school                    13            23                                     
   College                        5                                                    
  Marital status                                                         10.08         0.022[\*](#tfn3-cpn-16-407){ref-type="table-fn"}
   Single (unmarried, divorced)   40 (78.4)     44 (86.3)                              
   Married                        11 (21.6)     7 (13.7)                               
  Social economic status                                                               
   Low                            3             2                                      
   Low to middle                  13            12                                     
   Middle                         32            17                                     
   Middle to high                 2             17                                     
   High                           0             3                                      
  CAARS-In                        22.27±6.99    11.51±50.32                            0.000[\*](#tfn3-cpn-16-407){ref-type="table-fn"}
  CAARS-Hy                        18.67±7.66    12.16±50.25                            0.000[\*](#tfn3-cpn-16-407){ref-type="table-fn"}
  CAARS-Im                        20.31±7.45    10.51±60.24                            0.000[\*](#tfn3-cpn-16-407){ref-type="table-fn"}
  CAARS-Sc                        12.20±4.57    7.35±40.46                             0.000[\*](#tfn3-cpn-16-407){ref-type="table-fn"}
  BDI                             19.33±10.66   8.57±70.33                             0.000[\*](#tfn3-cpn-16-407){ref-type="table-fn"}
  STAI-T                          55.71±12.95   41.24±100.45                           0.000[\*](#tfn3-cpn-16-407){ref-type="table-fn"}
  SDS 1                           5.36±3.45     4.04±20.84                             0.038[\*](#tfn3-cpn-16-407){ref-type="table-fn"}
  SDS 2                           5.61±3.23     4.35±20.54                             0.032[\*](#tfn3-cpn-16-407){ref-type="table-fn"}
  SDS 3                           5.76±3.15     4.02±20.83                             0.004[\*](#tfn3-cpn-16-407){ref-type="table-fn"}
  SDS total                       16.73±8.66    12.41±70.09                            0.007[\*](#tfn3-cpn-16-407){ref-type="table-fn"}

Values are presented as mean±standard deviation, number only or number (%).

ADHD, attention deficit hyperactivity disorder; CAARS, Conners' Adult ADHD Rating Scale; CAARS-In, CAARS inattention/memory problems; CAARS-Hy, CAARS hyperactivity/restlessness; CAARS-Im, CAARS impulsivity/emotional lability; CAARS-Sc, CAARS problems with self-concept; BDI, Beck Depression Inventory; STAI-T, Spielberg Trait Anxiety Inventory; SDS, Sheehan Disability Scale; SDS 1, SDS work/school; SDS 2, SDS social life/leisure activities; SDS 3, SDS family life/home responsibilities.

*p*\<0.05.

###### 

Correlations between SDS and psychological symptoms in patients with ADHD

                 1                                                      2                                                      3                                                      4                                                      5                                                      6
  -------------- ------------------------------------------------------ ------------------------------------------------------ ------------------------------------------------------ ------------------------------------------------------ ------------------------------------------------------ ------------------------------------------------------
  1\. SDS                                                                                                                                                                                                                                                                                           
  2\. CAARS-In   0.379[\*\*](#tfn6-cpn-16-407){ref-type="table-fn"}                                                                                                                                                                                                                                 
  3\. CAARS-Hy   0.401[\*\*](#tfn6-cpn-16-407){ref-type="table-fn"}     0.369[\*\*](#tfn6-cpn-16-407){ref-type="table-fn"}                                                                                                                                                                          
  4\. CAARS-Im   0.598[\*\*\*](#tfn7-cpn-16-407){ref-type="table-fn"}   0.578[\*\*\*](#tfn7-cpn-16-407){ref-type="table-fn"}   0.663[\*\*\*](#tfn7-cpn-16-407){ref-type="table-fn"}                                                                                                                 
  5\. CAARS-Sc   0.296[\*](#tfn5-cpn-16-407){ref-type="table-fn"}       0.577[\*\*\*](#tfn7-cpn-16-407){ref-type="table-fn"}   0.187                                                  0.460[\*\*](#tfn6-cpn-16-407){ref-type="table-fn"}                                                            
  6\. BDI        0.562[\*\*\*](#tfn7-cpn-16-407){ref-type="table-fn"}   0.430[\*\*](#tfn6-cpn-16-407){ref-type="table-fn"}     0.379[\*\*](#tfn6-cpn-16-407){ref-type="table-fn"}     0.588[\*\*\*](#tfn7-cpn-16-407){ref-type="table-fn"}   0.432[\*\*](#tfn6-cpn-16-407){ref-type="table-fn"}     
  7\. STAI-T     0.669[\*\*\*](#tfn7-cpn-16-407){ref-type="table-fn"}   0.653[\*\*\*](#tfn7-cpn-16-407){ref-type="table-fn"}   0.428[\*\*](#tfn6-cpn-16-407){ref-type="table-fn"}     0.664[\*\*\*](#tfn7-cpn-16-407){ref-type="table-fn"}   0.690[\*\*\*](#tfn7-cpn-16-407){ref-type="table-fn"}   0.754[\*\*\*](#tfn7-cpn-16-407){ref-type="table-fn"}

SDS, Sheehan Disability Scale; ADHD, attention deficit hyperactivity disorder; CAARS, Conners' Adult ADHD Rating Scale; CAARS-In, CAARS inattention/memory problems; CAARS-Hy, CAARS hyperactivity/restlessness; CAARS-Im, CAARS impulsivity/emotional lability; CAARS-Sc, CAARS problems with self-concept; BDI, Beck Depression Inventory; STAI-T, Spielberg Trait Anxiety Inventory.

*p*\<0.05,

*p*\<0.01,

*p*\<0.001.
